Replies to post #181585 on Elite Pharmaceuticals Inc (ELTP)

[lasers]

ELI-201 and ELI-202 FDA Clinical Trial as per the ELI-200 Safety and Efficacy trial, are expected to exclude ALL patients that are currently taking opioid drugs for an existing medical condition.

Exclusion Criteria:

Have an uncontrolled medical condition, serious intercurrent illness, clinically significant general health condition, or extenuating circumstance that may significantly decrease study compliance or otherwise preclude their participation in the study.

https://clinicaltrials.gov/ct2/show/NCT02401750

[dr_lowenstein]

All of ELTPs ADFs ELIs Antagonist sequestered bead contains 50 mg Naltrexone to prevent addicted abuse as the Agonist and Antagonist cannot be separated.

wow!!! 50 mg of nal for just 5 mg of oxy??? hard to believe